This is consistent with data from prior studies showing a lack of correlation between ER/PR status with Ki67 in patients with ILC, but a strong inverse relationship in those with invasive ductal carcinoma [10]. The gene discussed is MKI67; the disease is invasive ductal breast carcinoma.